I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma

Abstract Background I-124 codrituzumab (aka GC33), an antibody directed at Glypican 3, was evaluated in patients with hepatocellular carcinoma (HCC). Fourteen patients with HCC underwent baseline imaging with I-124 codrituzumab (~ 185 MBq, 10 mg). Seven of these patients undergoing sorafenib/immunot...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Jorge A. Carrasquillo, Joseph A. O’Donoghue, Volkan Beylergil, Shutian Ruan, Neeta Pandit-Taskar, Steven M. Larson, Peter M. Smith-Jones, Serge K. Lyashchenko, Norihisa Ohishi, Toshihiko Ohtomo, Ghassan K. Abou-Alfa
格式: Artigo
語言:Inglês
出版: SpringerOpen 2018-03-01
叢編:EJNMMI Research
主題:
Codrituzumab
I-124
Antibody
Glypican
Hepatocellular
在線閱讀:http://link.springer.com/article/10.1186/s13550-018-0374-8
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍